chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache; Blood sugar was 274 and normally it is 110 to 115; had no energy/was stuck at home because he was totally down; did not move at all; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (had no energy/was stuck at home because he was totally down), HYPOKINESIA (did not move at all), BLOOD GLUCOSE INCREASED (Blood sugar was 274 and normally it is 110 to 115) and HEADACHE (headache) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939909, 025A21A and 028A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN for Diabetes.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, the patient experienced ASTHENIA (had no energy/was stuck at home because he was totally down) and HYPOKINESIA (did not move at all). On 03-Dec-2021, the patient experienced BLOOD GLUCOSE INCREASED (Blood sugar was 274 and normally it is 110 to 115). On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, ASTHENIA (had no energy/was stuck at home because he was totally down), HYPOKINESIA (did not move at all), BLOOD GLUCOSE INCREASED (Blood sugar was 274 and normally it is 110 to 115) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Dec-2021, Blood glucose: 274 (High) Patient reported his blood sugar was 274 and normally it was 110 to 115.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was on metformin for diabetes, but after the events he doubled his medication.  He thinks that his side effects may be because he did not move yesterday and part may be due to the booster dose. Patient is planning to go for a walk and If it does not get better in a couple of days he will contact his doctor.
sore feet; aches and pains; tendon soreness; aches and pains from it in my joints; Problems in my feet; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 63 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 18Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. Relevant medical history included: "tendon soreness" (unspecified if ongoing), notes: after taking some antibiotics. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "recovering", described as "sore feet"; PAIN (non-serious) with onset Mar2021, outcome "recovering", described as "aches and pains"; TENDON PAIN (non-serious) with onset Mar2021, outcome "recovering", described as "tendon soreness"; ARTHRALGIA (non-serious) with onset Mar2021, outcome "unknown", described as "aches and pains from it in my joints"; MUSCULOSKELETAL DISORDER (non-serious) with onset Mar2021, outcome "recovering", described as "Problems in my feet".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
vertigo, near fainting multiple times (loss of vision, dizziness, pressure in head, and feeling faint upon standing), heart palpitations, shortness of breath, migraine with increased blood pressure by 30 mm Hg systolic
Mild headache and fatigue 1/13 after the vaccine administration  1/14 starting around 1400: increase in muscle aches, headache, fatigue and chills  rested and took motrin  Expected site pain
Palpitations and chest pain Seen in ER on 7/8/21 and admitted overnight with rising troponin levels, improved by next day.  Diagnosis of myocarditis related to COVID19 vaccine
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. Concomitant therapies included sterile diluent (manufacturer unknown). On 01-SEP-2017, the patients were vaccinated with improperly stored VARIVAX (dose, frequency and route were unknown, lot # M049127, expiration date: 15-DEC-2018, lot # N010107, expiration date: 28-MAR-2019) for prophylaxis. Administered vaccine experienced the temperature excursion of -14 Celsius degree to -10 Celsius degree (-14.2 Celsius degree) for 6 hours. There was no previous temperature excursion. Data logger was involved. No adverse effects reported. No product quality complaint (PQC) was involved. This is one of several reports from the same reporter. All telephone attempts on 10-OCT-2017 to obtain follow up information have been unsuccessful. Follow up information has been received from an other reporter concerning a 12 month old patient. On 29-SEP-2017, the patient vaccinated with improperly stored VARIVAX (dose, frequency and route were unknown, lot # N008077, expiration date: 09-MAR-2019) for prophylaxis. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1709USA002098: US-009507513-1709USA002186.
injection site red; injection site swollen; injection site itchy; injection site inflammed; itch- spread to upper chest; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE ERYTHEMA (injection site red), INJECTION SITE SWELLING (injection site swollen), INJECTION SITE PRURITUS (injection site itchy), INJECTION SITE INFLAMMATION (injection site inflammed) and PRURITUS (itch- spread to upper chest) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 immunization.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included MONASCUS PURPUREUS, NICOTINAMIDE, PHYTOSTEROLS NOS (RED YEAST RICE WITH PLANT STEROLS) for Cholesterol.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (injection site red), INJECTION SITE SWELLING (injection site swollen), INJECTION SITE PRURITUS (injection site itchy), INJECTION SITE INFLAMMATION (injection site inflammed) and PRURITUS (itch- spread to upper chest). In January 2021, INJECTION SITE ERYTHEMA (injection site red), INJECTION SITE SWELLING (injection site swollen), INJECTION SITE PRURITUS (injection site itchy), INJECTION SITE INFLAMMATION (injection site inflammed) and PRURITUS (itch- spread to upper chest) had resolved.            Patient treated herself with one Benadryl. The events resolved within 24-hours.
Pruritic generalized rash 3-4 days after vaccine, not at site of injection, but in clusters of papules/plaques on extremities, trunk and face with sloughing of skin.  No systemic symptoms.
Sudden fever onset.  Lasted 3 days.  Controlled somewhat with Tylenol.
Pt recv vax on 2/9/99; on 2/11/99 pt exp swollen,sore, red vax site of LA w/ itching
Delayed erythema, warm to touch, induration surrounding injection sites.  On right upper anterior thigh.  Treated as cellulitis with cephalexin for 7 days.  Redness resolved.
Vaccine was diluted using the incorrect diluent  bacteriostatic normal saline was used instead of preservative-free normal saline.
Miller Fisher variant of GBS, weakness, headaches, facial paralysis, numbness in hands and toes.
Patient was given annual high dose influenza vaccine on 09/08/20. The next morning (09/09), the patient could not get out of bed. She ended up sliding out of bed and had to crawl over to a piece of furniture, and use that to pull herself up. She had difficulty sitting upright throughout the day without slumping over and ended up sleeping most of the day. She still had difficulty walking on 09/10 but the difficulties were more manageable. Throughout the time, patient has had redness, warmth and swelling on the arm between the vaccination site and the elbow, but not at the vaccination site. On Friday, 09/11, patient went to her doctor who gave her a shot of Rocephin and told her to take some benadryl and prednisone.
Had positive Covid-19 test on 12/3/2021, mild symptoms of congestion, low grade fever, cough. aching, and fatigue.  Unsure if related to injection or Covid-19, but on 12/15/21 had a day of vomiting and diarrhea.
I broke out in a terrible rash, Itched SO MUCH.  I was on vacation so I just took Benedryl (over the counter dose) and used Gold Bond anti itch cream.  When I retd. home on 4/18 I waited a few days to see if it would clear up. The itching was getting worse so I went to Urgent Care on 4/23/22. I was given a RX for 40 mg Prednisone and Hydroxzine 25 mg and told to see my Dr. as soon as I could.  On 4/26, I saw my Primary Care, she put me on 20 mg Prednisone and Hydroxzine 20 mg for 5 addl. days.  The rash started to disappear , BUT on 5/1 it came back. On 5/3 I saw Dr., who is a Dermatologist and he put me on a topical treatmet. Fluocinonide .05% Creamne . It was working, but on May 13, 2022 the rash and itch reappeared.
Half hour post vax pt went limp, listless and slept for two days and through both nights. When pt tried to awaken his eyes would roll back in head.
Patient said she felt fatigue the next day. On 10/14/19 she came into pharmacy saying that she also believes that the shot made her break out in rash throughout her upper body (abdomen, arms, face). She also reported an nodule on her head that resolved after taking ibuprofen. However, she still wants to get the second dose when due.
received Engerix B 3rd vax in series, had onset of itching at site of injection, firm mass noted under skin at site of injection, had onset of itching /w firm mass at inject site
Body aches, shaking, headache, dizziness, chills, sleeplessness
9/1/2021: Entyvio infusion in the morning, 9:30 am. First Pfizer dose in the afternoon, 3:00 pm - lot number FF2588. Virtually no reaction at all to the Pfizer first dose - no sickness, no drowsiness, nothing - felt fine. Suspected that Entyvio blocked Pfizer reaction.  Around 9/18/2021: Started having very mild hives and itching. Did not suspect the vaccine at this time.  9/22/2021: Second Pfizer dose in the afternoon - lot number FE3592. No immediate reaction.  9/23/2021: 24 hours after second dose, face and hands break out into significant hives and swelling (almost couldn?t get my rings off my fingers).  9/23 through 10/17/2021: Near daily severe hives, almost all over my body with varying severity depending on location that changed location daily - some days my face was worst, some my legs and feet, some my back and chest and shoulders, some my hands, some my head and neck, etc. Severe itching. Throat itching, difficulty/strange feeling swallowing, feeling of heart burn. Sweaty feet. Swelling in face, throat, hands, and feet varied daily. Got first pack of steroids on 9/25 (methylprednisolone), then progressively got stronger steroids (Prednisone then Dexamethasone) before finally getting some relief starting about 9/30. Stayed on steroids and antihistamine (mostly Benadryl) until symptoms abated enough to stop, which wasn?t until about 10/17/2021. Severity of hives and swelling nearly resulted in going to the ER several times, even after getting on steroids.  10/17/2021+: Symptoms mostly gone, with some odd days showing recurrence of mild hives and itching. Sweaty/clammy feet still persist, though not as intensely.  10/27/2021: Another Entyvio infusion. Vaccine reaction symptoms abated significantly after this infusion. Again, it is expect that the Entyvio is reducing the vaccine reaction.  11/27/2021: Mild symptoms are returning, suspected to be due to Entyvio concentration waning in my system. Experiencing strangeness in swallowing, mild itching, very mild hives, sweaty feet.  12/5/2021: Mild symptoms persist and are getting progressively, though very slightly, more intense. Itching, mild hives, throat/swallowing strangeness, and sweaty feet are still the primary complaints. Reporting on VAERS.
This spontaneous report received from a medical assistant refers to unspecified number of patients. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9, intramuscularly from a lot# M024261 with expiry date: 30-JUL-2018 (dose and anatomical location not reported), for prophylaxis. No adverse effects reported. The vaccine was exposed to a temperature excursion of 32 degree Fahrenheit and 36 degree Fahrenheit for 135 hours. The vaccine did not have previous temperature excursion. The temperature excursion was determined by digital data logger. No product quality complaint (PQC) involved. This is one of the three reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA011553: US-009507513-1701USA011552.
Feel cold/chill, body shaking, headache. The headache continues to the 3rd day.
Recipient presented to the vaccination site on 5/5/21 instead of 5/12/21 and received 2nd dose of COVID-19 vaccine.
About 3 hours after the vaccine, I could barley move my arm, headache. Nine hours after I had muscle aches, joint pains, my skin was so sensitive it was hard to walk, sit lay down- it just hurt so bad.  All night it was sensitive, I had chills, nausea, I couldn't sleep. My arm became swollen, red and hot to touch.  This pretty much lasted for three days and I just tried to control it with Tylenol and Benadryl, it was so awful and painful. Those three days were the worst of my life .  I called my Dr. and told me just continue to do what I was doing.
Extreme Tiredness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extreme Tiredness) and FATIGUE (Fatigue) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included METOPROLOL, ATORVASTATIN, GABAPENTIN and OXCARBAZEPINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Extreme Tiredness) and FATIGUE (Fatigue). At the time of the report, FATIGUE (Extreme Tiredness) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication details was reported.
Pt became light headed, dizzy and diaphoretic after GARDASIL was administered at 1420. Doctor notified and Pt was instructed to lay prone. Symptoms subsided at 1455.
The day of Sept 9, an itching began in the belly from the navel to the left side. The itch was all the time and not controlled. It formed a few hives. I went to the doctor Sept 15 and was diagnosed with Shingles. They medicated me with ZOVIRAX 800mg for 7 days.
Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: Warmth at injection site. Instructed patient to follow up with doctor if not resolved in another day
Swollen lymph node the size of a softball under her armpit/swollen lymph node on her collarbone the size of a softball; swelling under her armpit and chest; This is a spontaneous report from a contactable consumer female patient (Daughter) that:  A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: FF2587), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced swollen lymph node the size of a softball under her armpit/swollen lymph node on her collarbone the size of a softball and swelling under her armpit and chest. At the time of reporting, the outcome of the events were unknown.  Follow-up attempts are completed. No further information is expected.
dry cough; ached all over; felt like I was in a daze / Nothing seemed real; left arm pain; feeling very fatigue; 0 appetite; nausea; temperature 102.3; chills; dizziness; nearly walking into things almost stagger; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL8982 and expiry date not reported), via intramuscular, administered in Arm Left, on 06Jan2021 20:00 (at the age of 47-year-old), as dose 1, single, for COVID-19 immunisation in hospital. The patient medical history was not reported. There were no concomitant medications. Patient did not receive any other vaccines within 4 weeks prior to COVID vaccination. Patient had no illness at the time of vaccination. On 15Jan2021, the patent worked at night shift. The patient went home to sleep. On 16Jan2021 19:00, the patient woke up with left arm pain tolerable. As evening went off, the patient was feeling very fatigue, 0 appetite, nausea, chills, temperature 102.3. The patient experienced dizziness at night of 16Jan2021 only, nearly walking into things almost stagger, nerve sought any help with it and just slowed down went on normal until was resolved. The patient went back to bed till next day. The patient felt same on the next day (17Jan2021) and still had increased temperature but not so high. The patient experienced aches all over and felt like in a daze the whole day and nothing seemed real. The patient experienced dizziness at night Arm felt as though was hit with a board and no redness. It was reported that no residual effects from this except occasional dry cough, but it was also almost allergy senses, so not sure that vaccine was related. Patient received no treatment for the events. The outcome for dry cough was not recovered while for other events was recovered.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a medical assistant refers to a female patient of unknown age. On 06-OCT-2014, the patient purchased a dose of ZOSTAVAX at 1:30 PM from a pharmacy and she arrive at the physician's practice with the dose of ZOSTAVAX at 1:45 PM. The patient transported ZOSTAVAX to physician's office. The dose of ZOSTAVAX was administered (lot# J002693, expire date 07-JUN-2014, strength, dose, frequency and route unspecified) soon thereafter on the same day. Temperature range and timeframe of excursion, during transport to physician's office were not known. The worst case scenario would be that the dose of ZOSTAVAX was transported in a car in the 70's F outdoors, and exposed to temperatures as high as 77F or higher for less than 1 hour. The pharmacy put the vial of ZOSTAVAX in a plastic bag, and the pharmacy mislabeled the bag with the wrong expiration date, 06-OCT-2015. The dose of ZOSTAVAX was administered to the patient before the pharmacy's error was identified. There was no product quality complaint (PQC), the expiration dates not matching on the bag and the vial was the pharmacy's error. No adverse effect had been demonstrated or observed. The outcome of the events was unknown. Additional information has been requested.
Patient called 10-30-13 stating arm still hurts where flu shot was given 8-30-13.
Red itchy arm swollen glands + throat approximately 6 hrs after malaise red eyes/matter Tx BENADRYL
Headache-Same day as vaccine. Nausea, Headache, muscle aches, chills, 98.0 temp -1 day after. Diarrhea, Nausea -3rd day
16 y/o female erroneously received pfizer booster.   NO side effects reported during observation period.
This spontaneous report as received from a health professional, refers to unspecified number of patients of unknown demography. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, unspecified number of patients were vaccinated with improperly stored VAQTA injection (strength, dose, route and lot number or batch number unspecified). No concomitant medications were reported. No adverse effects were reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
1/22/21-itchy rash on both arms, still had today 1st SARS vaccine  2/12/2021-itchy rash on chest, continued rash on arms 2nd SARS vaccine  using Gold Bond anti itch cream
Pt had redness/watering of eyes. Reaction similar to pt history of allergic reaction to thimerosal (in eye drops). However, thimerosal - free prefilled syringe was used.
pt recvd vax & exp cramping, sore & achy joints, headache & trouble walking for next 2 wks;
Mother states she woke up during the night (3 AM) and daughter was starring into space (2 min.). Mother called 911. Daughter had 104 fever, vomited then given TYLENOL. EMT left after about 15 minutes. No lasting effects.
0.25 ml fluviron given.  Rec 74 years.  No reaction.
Severe nausea; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E96955) via an unspecified route of administration in the arm right on 02Apr2021 at 19:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) and piroxicam (PAXIL) both from unknown date for unknown indication taken within 2 weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm right on 05Mar2021 at 19:15 (at the age of 34-year-old)  as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Apr2021 at 23:00 the patient experienced severe nausea. No therapeutic measures are taken as a result of the event. The clinical outcome of the event severe nausea  was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.